Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0037315 (
sleep apnea
)
8,000
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We investigated brainstem auditory evoked potentials (BAEP) in 20 infants at risk of SIDS (age 5 days to 4 months) and in 7 control infants (age 5 days to 4 months). 19 infants were diagnosed as having
sleep apnea syndrome
(
SAS
), which we consider to be a possible risk factor for SIDS. The diagnosis of
SAS
was made in general in the presence of clinical symptoms such as apneas, cyanosis during sleep, poorly coordinated sucking, swallowing and respiration and gastro-oesophageal reflux in combination with an abnormal pneumogramm in a one hour oxycardiorespirography. One infant had the history of a near miss event but a normal pneumogramm, 2 infants, both with
SAS
, were siblings of SIDS infants. We applied BAEP on 12 infants at risk of SIDS with and on 12 infants at risk of SIDS without aminophyllin treatment. 3 infants at risk of SIDS had two BAEP studies, one before and one during aminophyllin treatment. The time interval between these two studies was 1 week to 16 days.
Aminophyllin
, given only to infants with
SAS
was administered orally (therapeutic range 4-10 micrograms/ml). All infants at risk of SIDS and all control infants had normal I-V-IPL (below 2 x SD). There was a tendency to longer I-V IPL in infants at risk of SIDS. When infants at risk of SIDS with and without aminophyllin treatment were compared as a group the I-V-IPL was shorter in the infants with aminophyllin. BAEP can be useful in studying disturbances of the autonomic function of brainstem centers but do not allow the prediction of an individual SIDS risk.
...
PMID:[Acoustically evoked brain stem potentials in infants at risk for SIDS with and without aminophylline therapy]. 279 43
Infants with a higher incidence of frequent and prolonged apneas during sleep (
sleep apnea syndrome
) as a consequence of a delayed maturation of respiratory control, have an increased risk for respiratory problems after anesthesia. In 12 babies (one to five months old) showing visible apneas with cyanosis up to 12 hours after herniotomies, the respiratory pattern was examined by impedance pneumography during spontaneous sleep. The mean apnea duration (M.A. value) amounted to 8,6 +/- 5,96 sec/min, whereas the M.A. value of a comparable control group was significantly lower (2,97 +/- 2,13 sec/min)
Aminophylline
prophylaxis of risk infants diminished significantly the frequency of postoperative respiratory complications.
...
PMID:[Early diagnosis of central respiratory disorders in infants to avoid postoperative complications]. 683 35
Aminophylline
is known to have respiratory stimulant properties, and it has been suggested that it may also be effective in
sleep apnoea
. However, its role in this disorder remains uncertain. Theoretically, increasing upper airway motoneural activity in order to maintain airway patency might alleviate obstructive
sleep apnoea
. On the other hand, increasing the respiratory drive may also prove beneficial in treating central
sleep apnoea
. In these studies, we attempted to determine the effect of aminophylline on neural activities of the upper airway and diaphragm. We administered intravenously either a low dose (4 mg.kg-1) or a high dose (16 mg.kg-1) of aminophylline to decerebrated, vagotomized and paralysed cats, and continuously recorded the phrenic hypoglossal and recurrent laryngeal nerve activities for 3 h. Results showed that a high dose of aminophylline induced a marked increase in phrenic nerve activity, but not hypoglossal or recurrent laryngeal nerve activity. In a group treated with a low dosage of aminophylline, a significant increase of activity was found in all three nerves. Furthermore, phrenic nerve activity increased more with a high dose than with a low dose. We confirmed that aminophylline has dose-dependent and selective effects on respiratory neural activity. A low dose acts on the upper airway and diaphragm, but a high dose induces a marked increase in central respiratory drive. According to our results, low dose aminophylline might be beneficial in obstructive
sleep apnoea
, whereas, a high or low dose might improve some cases of central
sleep apnoea
.
...
PMID:Changes in phrenic, hypoglossal and recurrent laryngeal nerve activities after intravenous infusions of aminophylline in cats. 766 65